Abl Diagnostics Sa Stock EBITDA
| ABLD Stock | 2.40 0.10 4.00% |
AbL Diagnostics SA fundamentals help investors to digest information that contributes to AbL Diagnostics' financial success or failures. It also enables traders to predict the movement of AbL Stock. The fundamental analysis module provides a way to measure AbL Diagnostics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to AbL Diagnostics stock.
AbL |
AbL Diagnostics SA Company EBITDA Analysis
AbL Diagnostics' EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
According to the company disclosure, AbL Diagnostics SA reported earnings before interest,tax, depreciation and amortization of 0.0. This is 100.0% lower than that of the Industrials sector and 100.0% lower than that of the Railroads industry. The ebitda for all France stocks is 100.0% higher than that of the company.
AbL EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses AbL Diagnostics' direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of AbL Diagnostics could also be used in its relative valuation, which is a method of valuing AbL Diagnostics by comparing valuation metrics of similar companies.AbL Diagnostics is currently under evaluation in ebitda category among its peers.
AbL Fundamentals
| Return On Equity | -0.0612 | |||
| Return On Asset | -0.0402 | |||
| Current Valuation | 26.3 M | |||
| Shares Outstanding | 2.01 M | |||
| Shares Owned By Insiders | 12.08 % | |||
| Price To Book | 11.59 X | |||
| Price To Sales | 1,000,000 X | |||
| Gross Profit | (101.62 K) | |||
| Net Income | 257.87 K | |||
| Cash And Equivalents | 2.7 M | |||
| Book Value Per Share | 1.25 X | |||
| Cash Flow From Operations | (56.69 K) | |||
| Earnings Per Share | (0.08) X | |||
| Beta | -0.13 | |||
| Market Capitalization | 23.76 M | |||
| Total Asset | 2.71 M | |||
| Net Asset | 2.71 M |
About AbL Diagnostics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze AbL Diagnostics SA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AbL Diagnostics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AbL Diagnostics SA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in AbL Stock
AbL Diagnostics financial ratios help investors to determine whether AbL Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in AbL with respect to the benefits of owning AbL Diagnostics security.